NORDIC NANOVECTOR AS

NANO
Real-time Estimate Quote. Real-time Estimate  - 11/23 10:20:00 am
15.275NOK +2.59%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Nordic Nanovector ASA is a Norway-based company active in the biotechnology industry. It is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product candidate is Betalutin, comprising a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide (Lutetium 177). It is designed improve treatment of Non-Hodgkin Lymphoma (NHL) and advanced through clinical development. Additionally, the Company is engaged in the development of its Antibody-Radionuclide-Conjugate (ARC) portfolio to treat various selected cancer indications. It has two subsidiaries, Nordic Nanovector GmbH and Nordic Nanovector Ltd.

Number of employees : 48 people.
Managers
Name Title
Lars Nieba Chief Executive & Technology Officer
Jan Hendrik Egberts Chairman
Marco Renoldi Chief Operating Officer
Malene Brondberg Chief Financial Officer
Jostein Dahle Chief Scientific Officer
Christine Wilkinson-Blanc Chief Medical Officer
Per Anders Göte Samuelsson Independent Director
Hilde Hermansen Steineger Independent Director
Jean-Pierre Bizzari Independent Director
Joanna C. Horobin Independent Non-Executive Director
Shareholders
Name Equities %
HealthCap AB 6,165,378 8.50%
Folketrygdfondet 3,663,715 5.05%
Ole Morten Halvorsen 2,565,352 3.54%
Nordea Investment Management AB (Norway) 1,975,618 2.72%
Storebrand Asset Management AS 1,195,422 1.65%
Roy Hartvig Larsen 1,187,801 1.64%
KLP Kapitalforvaltning AS 1,071,845 1.48%
Linux Solutions Norge AS 845,071 1.16%
Pĺl-Erik Robinson 800,000 1.10%
Must Family 700,000 0.96%
Company contact information
Nordic Nanovector ASA
Kjelsasveien 168 B
Oslo 0884

Phone : +47.22.18.33.01
Fax : +47.22.58.00.07
Web : http://www.nordicnanovector.com
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
NORDIC NANOVECTOR ASA-53.09%131
GILEAD SCIENCES, INC.-7.49%75 350
VERTEX PHARMACEUTICALS-1.71%55 963
REGENERON PHARMACEUTICALS38.15%54 750
WUXI APPTEC CO., LTD.63.37%35 488
BEIGENE, LTD.71.43%25 903
BIONTECH SE207.17%25 059
GENMAB A/S54.71%23 871
ARGENX SE56.69%12 633
HUALAN BIOLOGICAL ENGINEERING INC.57.18%12 007
MYOKARDIA, INC.208.58%11 993
MIRATI THERAPEUTICS, INC.76.07%11 408
SAREPTA THERAPEUTICS, INC.1.66%10 352
ASCENDIS PHARMA A/S12.49%8 360
NEUROCRINE BIOSCIENCES, INC.-17.20%8 315
ULTRAGENYX PHARMACEUTICAL INC.167.78%7 566
DENALI THERAPEUTICS INC.257.92%7 477
KODIAK SCIENCES INC.94.58%7 058
ARROWHEAD PHARMACEUTICALS, INC.8.47%7 038
ACCELERON PHARMA INC.114.15%6 841
BIOCON LIMITED42.99%6 715